Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2291 studies found for:    "Fibrinolytic Agents"
Show Display Options
Rank Status Study
1 Unknown  Thrombolytic Therapy Versus Surgery for Obstructive Prosthetic Valve Thrombosis
Condition: Obstructive Thrombus
Interventions: Drug: Thrombolytic Therapy;   Procedure: Surgery
2 Completed Efficacy and Security of an Endovascular Treatment as First Choice Procedure Compared With a Standard Intravenous Thrombolytic Therapy Treatment for Patients With Acute Ischemic Stroke Within 4.5 Hours After Onset
Condition: Acute Ischaemic Stroke
Interventions: Procedure: EVT (endovascular treatment );   Procedure: IVT (intravenous thrombolytic therapy)
3 Recruiting Registry of Patient With Antithrombotic Agents Admitted to an Emergency Department
Condition: Antithrombotic Agents
Intervention: Other: emergency
4 Unknown  Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly
Condition: Myocardial Infarction
Interventions: Drug: Thrombolytic therapy;   Procedure: Percutaneous coronary intervention (PCI)
5 Completed Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization
Conditions: Heart Disease;   Myocardial Infarction;   Acute Myocardial Infarction
Interventions: Drug: Retavase 10 U IV Bolus;   Procedure: Angioplasty/Heart Catheterization;   Device: Drug eluting stent placed in heart attack related artery
6 Completed EUS-FNA for Patients With Antithrombotic Agents
Condition: Solid Tumor
Intervention:
7 Active, not recruiting The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery
Condition: Acetabular Fractures
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
8 Unknown  Safety of Intravenous Thrombolytics in Stroke on Awakening
Condition: Stroke
Intervention: Drug: rt-PA
9 Completed Pre-stroke Cognitive Status and Thrombolytic Therapy
Conditions: Brain Ischemia;   Adverse Effect of Thrombolytic Drugs;   Impaired Cognition;   Dementia
Intervention:
10 Not yet recruiting Surgery Versus Fibrinolytic Therapy for Left-sided Prosthetic Heart Valve Thrombosis
Condition: Left-sided Prosthetic Heart Valve Thrombosis
Interventions: Procedure: Emergency surgery;   Drug: Fibrinolytic therapy
11 Not yet recruiting r-tPA Thrombolytic Therapy in Combination With Remote Ischemic Conditioning for Acute Ischemic Stroke Recovery
Condition: Stroke, Acute
Intervention: Device: ischemic conditioning
12 Recruiting The Safety and Efficacy Study of High Dose Atorvastatin After Thrombolytic Treatment in Acute Ischemic Stroke
Condition: Stroke
Intervention: Device: atorvastatin
13 Not yet recruiting Local Thrombolytics Before Thrombectomy in STEMI
Condition: Coronary Artery Disease
Interventions: Drug: Urokinase;   Drug: Saline
14 Unknown  Enhancing Donated After Cardiac Death (DCD) Utilization With Thrombolytic Therapy
Conditions: Liver Transplantation;   Kidney Transplantation
Intervention: Drug: rTPA Treatment
15 Completed The Effect of Implementing Hyper-acute Stroke Guidelines on Decision-Making for or Against Thrombolytic Therapy for Stroke in the Emergency Department
Condition: Stroke
Intervention:
16 Completed Prospective Comparison of Cold Polypectomy and Conventional Polypectomy for Small Colorectal Polyps in Patients Taking Antithrombotic Agents
Condition: Colorectal Polyps
Intervention: Procedure: Cold polypectomy
17 Not yet recruiting Protective Effects of Normobaric Hyperoxia on Blood Brain Barrier in Patients With Acute Ischemic Stroke
Condition: Stroke, Acute
Intervention: Other: Normobaric oxygen therapy
18 Completed 12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China
Conditions: Pulmonary Embolism;   Thromboembolism
Intervention: Drug: Urokinase
19 Recruiting Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism
Condition: Pulmonary Embolism and Thrombosis
Intervention: Device: EkosSonic Endovascular System plus thrombolytic
20 Recruiting Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke
Conditions: Cerebral Infarction;   Brain Ischemia;   Stroke
Intervention: Drug: Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.